AI MARKET SCANNING

Genmab A/S -ADR

AVG HISTORICAL GAP +0.41%
MAX GAP RECORD +7.35%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $GMAB
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
+5.40%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
-5.54%
Feb 17, 2026 Earnings Release 2026-02-17 (UNDETERMINED)
+0.00%
Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN)
-1.20%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-5.86%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-3.15%
Feb 12, 2025 Earnings Release 2025-02-12 (AFTER CLOSE)
+2.13%
Nov 06, 2024 Earnings Release 2024-11-06 (BEFORE OPEN)
-2.42%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.1%
Bullish Gaps (6)
Bearish Gaps (8)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $GMAB

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗